ConditionGenitourinary Syndrome of Menopause
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorHospital Universitari de Bellvitge
About this trial
Vaginal laser together with the use of moisturizing and repairing gels could be an effective therapy for the treatment of genitourinary syndrome in women with a history of neoplasia in whom the use of estrogens is not recommended.
The purpose of this study is to evaluate the effectiveness of vaginal laser together with adjuvant treatment with a hydrating and repairing niosomal gel as a beneficial treatment in this group of patients.
Eligibility criteria
Qualifiers
Patients with an established SGM diagnosis.
Patients with a history of neoplasia in whom the use of estrogens as the first alternative for the treatment of GMS is not recommended.
Disqualifiers
Patients with concomitant vulvovaginal pathology.
Patients with a diagnosis of pelvic organ prolapse grade II or greater.
Trial design
Treatments tested in this trial
- CO2 laser
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov